AC Immune SAACIUEarnings & Financial Report
Nasdaq
ACIU Q2 2025 Key Financial Metrics
营收
$1.4M
毛利润
N/A
营业利润
$-21.3M
净利润
$-23.3M
毛利率
N/A
营业利润率
-1484.5%
净利率
-1622.4%
同比增长
90.1%
资金流向
AC Immune SA Q2 2025 Financial Summary
AC Immune SA reported revenue of $1.4M (up 90.1% YoY) for Q2 2025, with a net profit of $-23.3M (up 6.9% YoY) (-1622.4% margin). Cost of goods sold was N/A.
Key Financial Metrics
| Total Revenue | $1.4M |
|---|---|
| Net Profit | $-23.3M |
| Gross Margin | N/A |
| Operating Margin | -1484.5% |
| Report Period | Q2 2025 |
AC Immune SA Quarterly Revenue & Net Profit History
AC Immune SA quarterly results over the last 3 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q2 2025 | $1.4M | +90.1% | $-23.3M | -1622.4% |
| Q2 2024 | $755.7K | — | $-25.0M | -3313.0% |
| Q3 2022 | $4.3M | — | $-14.9M | -343.6% |
利润表
| Q3 2022 | Q2 2024 | Q2 2025 | |
|---|---|---|---|
| 营收 | $4.3M | $755700 | $1.4M |
| 同比增长 | N/A | N/A | 90.1% |
资产负债表
| Q3 2022 | Q2 2024 | Q2 2025 | |
|---|---|---|---|
| 总资产 | $226.1M | $261.3M | $209.2M |
| 总负债 | $17.1M | $125.5M | $127.0M |
| 股东权益 | $209.1M | $135.8M | $82.2M |
现金流量表
No data available for this period